Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors
Clinical trial NCT02478866 · COMPLETED
Trial details
- NCT number
- NCT02478866
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-11
- Primary completion
- 2017-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.